Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, facilitating targeted treatment or absorption of active ingredients. It is used to treat conditions such as Polycystic Ovary Syndrome, Acne, Hirsutism, Hyperandrogenism, and Menopausal Symptoms.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specially compounded topical gel formulation of Metformin HCl 5%/Progesterone 1%/Spironolactone 2%. This unique formulation is specifically designed to address a range of skin conditions, including acne, rosacea, and seborrheic dermatitis.
The Metformin HCl component of this formulation is an antihyperglycemic agent that works to reduce inflammation and enhance skin health. Progesterone, a hormone, contributes to the reduction of sebum production and inflammation. Spironolactone, an antiandrogen, also aids in reducing sebum production and inflammation.
This combination of active ingredients works synergistically to reduce inflammation, decrease sebum production, and improve overall skin health.
The formulation is a semisolid compound dispensed through a pump mechanism, which allows for easy and precise application on the skin. This targeted treatment ensures that the active ingredients are absorbed effectively in a gel-like consistency, providing optimal results.
If you have any queries about this formulation or how it can assist in treating your specific skin condition, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you find the most suitable treatment for your skin condition.
Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded formulation designed to address a range of health conditions. Metformin HCl, an oral antidiabetic medication, is used in the treatment of type 2 diabetes. Progesterone, a hormone, is utilized in the management of conditions such as abnormal uterine bleeding, endometriosis, and infertility. Spironolactone, a diuretic, is employed in the treatment of hypertension, edema, and congestive heart failure.
When combined in this unique formulation, Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel can help alleviate the symptoms of these conditions. However, it is crucial to understand that this formulation should not replace other prescribed medications for these conditions, but rather serve as an adjunct treatment.
Patients should be aware that Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel may cause skin irritation, redness, or itching. If any of these side effects occur, it is recommended to contact a healthcare provider immediately.
Healthcare providers should be cognizant of potential interactions between Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel and other medications, including oral antidiabetic medications, hormones, and diuretics. Regular monitoring of patients' conditions is advised while they are on this medication.
If you have any questions or concerns about Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel, it is recommended to reach out to a healthcare provider or pharmacist for further information and guidance.
Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded medication designed for targeted treatment of various skin conditions. This unique formulation combines three active ingredients: Metformin HCl, Progesterone, and Spironolactone, each with its own therapeutic benefits.
Metformin HCl, primarily known as an antidiabetic medication, plays a crucial role in this formulation by reducing blood sugar levels. When applied topically, it helps to decrease the production of glucose in the skin, thereby reducing inflammation.
Progesterone, a hormone that regulates the menstrual cycle, is used in this formulation to treat abnormal uterine bleeding. Topically, it aids in reducing the production of sebum, a substance that can cause skin irritation when produced in excess.
Spironolactone, a diuretic, is included in this formulation for its ability to reduce fluid retention. This property is beneficial in treating high blood pressure and, when applied topically, it can help reduce swelling in the skin.
This combination medication is designed to treat a variety of skin conditions, including acne, rosacea, and eczema. The gel-like consistency of this formulation allows for easy and precise application on the skin, ensuring targeted treatment and absorption of the active ingredients.
Understanding the unique properties and benefits of each ingredient in this compounded formulation can help you better understand how it works to treat your specific skin condition. If you have any questions about this formulation, please don't hesitate to reach out for more information.
This Metformin HCl 5%/Progesterone 1%/Spironolactone 2% Topical Gel is a compounded formulation that has been effectively used in the treatment of a variety of conditions. It has been particularly beneficial in managing Polycystic Ovary Syndrome, Acne, Hirsutism, Hyperandrogenism, and Menopausal Symptoms. It has also shown efficacy in treating seborrheic dermatitis, alopecia, androgenic alopecia, and hirsutism.
Moreover, this formulation has been instrumental in reducing the risk of developing several conditions. It has been used to decrease the likelihood of ovarian cysts, endometrial hyperplasia, and endometrial cancer. It has also been beneficial in reducing the risk of acne, hirsutism, and hyperandrogenism.
Furthermore, this formulation has been used to mitigate the risk of developing menopausal symptoms, depression, and anxiety. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. If you have any questions about the use of this formulation, please do not hesitate to reach out.
This is a compounded formulation of Metformin HCl, Progesterone, and Spironolactone in a gel form. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism facilitates easy and precise application of the gel on the skin. It ensures that the right amount of gel is dispensed each time, reducing the risk of over or under-dosing.
The gel-like consistency allows for targeted treatment or absorption of the active ingredients. It is designed to adhere to the skin and provide a sustained release of the medication.
Apply the gel to the skin as directed by your healthcare provider. The pump mechanism will dispense the correct amount of gel for each application.
It is recommended to use this gel on the area of the skin as directed by your healthcare provider. Do not apply it to broken or irritated skin unless instructed by your healthcare provider.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose to catch up.
Side effects can vary depending on the individual and the dosage. Common side effects may include skin irritation or redness at the application site. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Before using other skincare products, consult with your healthcare provider. Some products may interfere with the absorption of the active ingredients in the gel.
Store the gel at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
If you suspect an overdose, contact a healthcare provider or poison control center immediately. Symptoms of an overdose may vary depending on the individual and the amount of gel applied.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
